Farmacosmo S p A : The Board of Directors Identifies the Beneficiaries of the 2022-2024 Stock Grant Plan

PRESS RELEASE

FARMACOSMO: THE BOARD OF DIRECTORS IDENTIFIES THE BENEFICIARIES

OF THE 2022-2024 STOCK GRANT PLAN, THE NUMBER OF RIGHTS TO RECEIVE FARMACOSMO ORDINARY SHARES TO BE GRANTED TO EACH OF THEM AND THE RELEVANT PERFORMANCE TARGETS

Naples, June 9th 2023

Farmacosmo S.p.A. ("Company", "Farmacosmo"), a company active in the Health, Pharma & Beauty sector, listed on the Euronext Growth Milan market of Borsa Italiana, announces that today the Board of Directors resolved to implement the stock incentive plan for employees called "Stock Grant Plan for Employees of Farmacosmo S.p.A. for the period 2022-2024" (the "Plan") - as approved by the Shareholders' Meeting of the Company on March 2nd 2022 and in accordance with the regulations of the Plan, approved by the Board of Directors on March 23rd 2022 (the "Regulations") -, identifying, with reference to the second of the three allocation cycles, the beneficiaries of the Plan and the number of rights to receive Farmacosmo ordinary shares to be allocated to each of them in accordance with the terms and conditions of the Rules, as well as determining the relevant performance targets upon the achievement of which the allocation of the shares to each beneficiary shall be subject, pursuant to the Regulations.

Specifically, the Board of Directors, with regard to the second assignment cycle, identified 16 beneficiaries among the Company's employees, to whom a total of 175,000 rights to receive ordinary shares of the Company were assigned - according to the terms and conditions set forth in the Regulation.

It should also be noted that the allocation in execution of the Plan of the aforesaid ordinary shares to the relevant beneficiaries will be conditioned, inter alia, as set forth in the Regulations, (i) on the individual beneficiary's achievement, during the financial year ending on December 31st 2023, of the individual performance objectives determined today by the Board of Directors and (ii) on the commencement of the vesting period set forth in the Plan Regulation.

***

The composition of the shareholding structure is available at www.farmacosmoinvestors.com,section "Investors/Info for shareholders".

This press release is available on the www.farmacosmoinvestors.comwebsite, section "Investors/Press Releases" and on the authorized storage mechanism "eMarket Storage" (www.emarketstorage.com).

***

THE SOCIETY

Farmacosmo is a company active in the Health, Pharma & Beauty sectors. The company's business model is based on the circular model of the l(ea)n strategy, and is divided into three main business areas: Logistics, Intelligence and Node. Logistics: enables the management and fulfillment of up to 12,000 orders per day, with delivery times of up to 20 hours from carrier picking and just-in time procurement ('zero warehouse' policy). Intelligence: includes strategy definition, competitive positioning and customer journey activities, which enabled the company to intercept c. 188,000 customers in 2021. Recurring customers contributed 74% of the annual retail stream turnover. The average cart value of active customers in the retail stream amounted to €92 (€109 related to recurring customers). Node: R&D activities, process innovation and IT infrastructure of the company. Over the past five years, Farmacosmo's sales value has grown by 54% (CAGR 2016-2021) and will be around €58 million in 2021. The Farmacosmo ecosystem aims to pursue standards of excellence in every part of its value chain, being inspired by compliance with ESG principles at all stages of the logistics process (from the packaging used for online orders to carbon compensation initiatives) and in the valorisation of its

1

www.farmacosmo.it

PRESS RELEASE

employees, the company's strategic asset. The portals ProfumeriaWeb, Phàrmasi, Bau Cosmesi and ContactU, an innovative platform of telepsychology launched in March 2023, are part of Farmacosmo Group. During 2022, Farmacosmo launched its rooting strategy through the acquisition of Farmacosmo-branded logistics pharmacies. Farmacosmo's commitment to ESG is also underlined by the publication of its Sustainability Report 2021.

IDENTIFICATION CODES

Ordinary Share: ISIN IT0005487670 (Ticker COSMO)

Warrant Farmacosmo 2022-2025: ISIN IT0005487415 (Ticker WCOSMO)

FOR FURTHER INFORMATIONS:
INVESTOR RELATIONS MANAGER	EURONEXT GROWTH ADVISOR	INVESTOR & MEDIA RELATIONS ADVISOR
Farmacosmo	illimity Bank	IR Top Consulting
Via Crispi, 51 - 80121 Napoli	Via Soperga, 9 - 20124 Milano	Via Bigli, 19 - 20121 Milano
Tel. [phone]	Tel. [phone]	Tel. [phone]
Paolo [e-mail]	[e-mail]	Pietro Autelitano [e-mail]
		Domenico [e-mail]

2

www.farmacosmo.it